Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 39

    1.

    Radiologist evaluation of an X-ray tube-based diffraction-enhanced imaging prototype using full-thickness breast specimens.

    Faulconer L, Parham C, Connor DM, Zhong Z, Kim E, Zeng D, Livasy C, Cole E, Kuzmiak C, Koomen M, Pavic D, Pisano E.

    Acad Radiol. 2009 Nov;16(11):1329-37. Epub 2009 Jul 10.PMID: 19596593 [PubMed - in process]Related articles

    2.

    FAK overexpression and p53 mutations are highly correlated in human breast cancer.

    Golubovskaya VM, Conway-Dorsey K, Edmiston SN, Tse CK, Lark AA, Livasy CA, Moore D, Millikan RC, Cance WG.

    Int J Cancer. 2009 Oct 1;125(7):1735-8.PMID: 19521985 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway.

    Courtwright A, Siamakpour-Reihani S, Arbiser JL, Banet N, Hilliard E, Fried L, Livasy C, Ketelsen D, Nepal DB, Perou CM, Patterson C, Klauber-Demore N.

    Cancer Res. 2009 Jun 1;69(11):4621-8. Epub 2009 May 19.PMID: 19458075 [PubMed - indexed for MEDLINE]Related articles

    4.

    A compact VEGF signature associated with distant metastases and poor outcomes.

    Hu Z, Fan C, Livasy C, He X, Oh DS, Ewend MG, Carey LA, Subramanian S, West R, Ikpatt F, Olopade OI, van de Rijn M, Perou CM.

    BMC Med. 2009 Mar 16;7:9.PMID: 19291283 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Use of the ThinPrep method in bile duct brushings: analysis of morphologic parameters associated with malignancy and determination of interobserver reliability.

    Waugh MS, Guy CD, Maygarden SJ, Livasy CA, Jones CK, Volmar KE.

    Diagn Cytopathol. 2008 Sep;36(9):651-6.PMID: 18677761 [PubMed - indexed for MEDLINE]Related articles

    6.

    Histological characteristics of singleton placentas delivered before the 28th week of gestation.

    Hecht JL, Allred EN, Kliman HJ, Zambrano E, Doss BJ, Husain A, Pflueger SM, Chang CH, Livasy CA, Roberts D, Bhan I, Ross DW, Senagore PK, Leviton A; Elgan Study Investigators.

    Pathology. 2008 Jun;40(4):372-6.PMID: 18446627 [PubMed - indexed for MEDLINE]Related articles

    7.

    Molecular characterization of human breast tumor vascular cells.

    Bhati R, Patterson C, Livasy CA, Fan C, Ketelsen D, Hu Z, Reynolds E, Tanner C, Moore DT, Gabrielli F, Perou CM, Klauber-DeMore N.

    Am J Pathol. 2008 May;172(5):1381-90. Epub 2008 Apr 10.PMID: 18403594 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues.

    Hecht JL, Onderdonk A, Delaney M, Allred EN, Kliman HJ, Zambrano E, Pflueger SM, Livasy CA, Bhan I, Leviton A; ELGAN Study Investigators.

    Pediatr Dev Pathol. 2008 Jan-Feb;11(1):15-22.PMID: 18237241 [PubMed - indexed for MEDLINE]Related articles

    9.

    Epidemiology of basal-like breast cancer.

    Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM.

    Breast Cancer Res Treat. 2008 May;109(1):123-39. Epub 2007 Jun 20. Erratum in: Breast Cancer Res Treat. 2008 May;109(1):141. Dressler, Lynn G [added]. PMID: 17578664 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Reference weights for placentas delivered before the 28th week of gestation.

    Hecht JL, Kliman HJ, Allred EN, Pflueger SM, Chang CH, Doss BJ, Roberts D, Livasy CA, Bhan I, Zambrano E, Ross DW, Senagore P, Husain AN, Leviton A.

    Placenta. 2007 Oct;28(10):987-90. Epub 2007 Jun 18.PMID: 17573110 [PubMed - indexed for MEDLINE]Related articles

    11.

    Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.

    Rivenbark AG, Livasy CA, Boyd CE, Keppler D, Coleman WB.

    Exp Mol Pathol. 2007 Oct;83(2):188-97. Epub 2007 Apr 18.PMID: 17540367 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Identification of a basal-like subtype of breast ductal carcinoma in situ.

    Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.

    Hum Pathol. 2007 Feb;38(2):197-204.PMID: 17234468 [PubMed - indexed for MEDLINE]Related articles

    13.

    Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively.

    Ollila DW, Klauber-DeMore N, Tesche LJ, Kuzmiak CM, Pavic D, Goyal LK, Lian J, Chang S, Livasy CA, Sherron RF, Sartor CI.

    Ann Surg Oncol. 2007 Feb;14(2):660-9.PMID: 17091330 [PubMed - indexed for MEDLINE]Related articles

    14.

    Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

    Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC.

    JAMA. 2006 Jun 7;295(21):2492-502.PMID: 16757721 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Axillary lymph node count is lower after neoadjuvant chemotherapy.

    Neuman H, Carey LA, Ollila DW, Livasy C, Calvo BF, Meyer AA, Kim HJ, Meyers MO, Dees EC, Collichio FA, Sartor CI, Moore DT, Sawyer LR, Frank J, Klauber-DeMore N.

    Am J Surg. 2006 Jun;191(6):827-9.PMID: 16720159 [PubMed - indexed for MEDLINE]Related articles

    16.

    The molecular portraits of breast tumors are conserved across microarray platforms.

    Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM.

    BMC Genomics. 2006 Apr 27;7:96.PMID: 16643655 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic.

    Klauber-DeMore N, Ollila DW, Moore DT, Livasy C, Calvo BF, Kim HJ, Dees EC, Sartor CI, Sawyer LR, Graham M 2nd, Carey LA.

    Ann Surg Oncol. 2006 May;13(5):685-91. Epub 2006 Mar 9.PMID: 16523367 [PubMed - indexed for MEDLINE]Related articles

    18.

    Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

    Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM.

    Mod Pathol. 2006 Feb;19(2):264-71.PMID: 16341146 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.

    Conway K, Parrish E, Edmiston SN, Tolbert D, Tse CK, Geradts J, Livasy CA, Singh H, Newman B, Millikan RC.

    Breast Cancer Res. 2005;7(6):R871-80. Epub 2005 Sep 6.PMID: 16280033 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.

    Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, Glas AM, Perou CM, Van't Veer LJ.

    Cancer Res. 2005 Oct 15;65(20):9155-8.PMID: 16230372 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...